Results 91 to 100 of about 1,659,457 (221)

CD5L, Macrophage Apoptosis Inhibitor, Was Identified in Epicardial Fat-Secretome and Regulated by Isoproterenol From Patients With Heart Failure

open access: yesFrontiers in Physiology, 2020
ObjectivesNeurohormonal dysfunction, which can regulate epicardial fat activity, is one of the main promoters of atrial fibrillation (AF) in patients with heart failure (HF).
Rosa M. Agra-Bermejo   +15 more
doaj   +1 more source

Targeting Overweight and Obesity Phenotypes for Secondary Prevention of Cardiovascular Disease: A Call to Action for the Middle East and Beyond

open access: yesObesity Reviews, EarlyView.
ABSTRACT Although there are conflicting clinical data on the efficacy of weight reduction in reducing secondary events in patients with comorbid overweight and obesity (OAO) and cardiovascular disease (CVD), there is excellent epidemiological and biological evidence of a cause–effect relationship between OAO, CVD, and other systemic complications ...
Wael Almahmeed   +19 more
wiley   +1 more source

Toward “Obesityomics”: Domain‐Specific Omics in Precision Obesity Medicine with a Brief AI Perspective

open access: yesObesity Reviews, EarlyView.
ABSTRACT Background Obesity's global rise has outpaced the effectiveness of “one‐size‐fits‐all” prevention and treatment strategies. The promise of precision medicine lies in addressing the etiological and biological diversity of obesity and transforming it into actionable endotypes.
Nadia Abu Samra   +13 more
wiley   +1 more source

Epicardial fat as an independent predictor of cardiovascular disease

open access: yesSiberian Journal of Life Sciences and Agriculture
Background.  In recent decades, there has been a paradigm shift in understanding the relationship between obesity and cardiovascular risk. Epicardial fat, as a metabolically active paracrine organ, is considered a potential independent predictor of ...
Anastasia A. Zyuzina   +4 more
doaj   +1 more source

Automatic Epicardial Fat Segmentation and Quantification of CT Scans Using Dual U-Nets With a Morphological Processing Layer

open access: yesIEEE Access, 2020
The epicardial fat plays a key role in the development of many cardiovascular diseases. It is necessary and useful to precisely segment this fat from CT scans in clinical studies.
Qi Zhang   +4 more
doaj   +1 more source

The Power of Two: Harnessing Dual Glucagon and Incretin Signaling for Treatment of Obesity and Metabolic Dysfunction–Associated Steatohepatitis—A Narrative Review with a Translational Focus

open access: yesObesity Reviews, EarlyView.
ABSTRACT A resurgence in glucagon research has repositioned this pancreatic hormone as a promising target in the treatment of obesity and related metabolic disorders. Glucagon is classically known for contributing to glucose homeostasis, but emerging evidence points to a much wider role in metabolism, including energy balance and liver health.
Jamy D. Ard, Jaime P. Almandoz
wiley   +1 more source

Epicardial Fat Thickness In Type 2 Diabetes Outpatient Care

open access: yes, 2023
Visceral fat is an independent predictor of the cardiovascular risk in subjects with type 2 diabetes (T2DM), but it is rarely assessed during an outpatient visit.
Jeffrey J. Goldberger   +14 more
core   +1 more source

Correlation of epicardial fat quantification with severity of coronary artery disease: A study in Indian population

open access: yesIndian Heart Journal, 2018
Objective: We studied the correlation of quantified epicardial fat with severity of coronary artery disease in patients [suspected cases of coronary artery disease (CAD)] referred for computed tomography (CT) coronary angiography and established cutoffs ...
Rishabh Khurana   +5 more
doaj   +1 more source

GLP‐1 Receptor Agonists and Cancer Risk in Obesity Treatment

open access: yesObesity Reviews, EarlyView.
ABSTRACT Obesity is a well‐established risk factor for numerous cancers, with body habitus, especially central adiposity, contributing to increased cancer incidence and worse prognosis. Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs), initially developed to treat Type 2 diabetes, have rapidly gained prominence as powerful anti‐obesity agents due ...
Lorne J. Hofseth   +6 more
wiley   +1 more source

Management of Congenital Complete Atrioventricular Block in Preterm Neonates With Novel Pacing Method

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Congenital complete atrioventricular block (CCAVB) is a rare autoimmune mediated disorder with a guarded prognosis, particularly when associated with extreme prematurity and severe bradycardia. Recent advances in neonatal care for extremely premature infants with delivery at level IV neonatal intensive care unit and novel pediatric pacing ...
Anusha Bai Kalithkar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy